Herold Advisors’s Nektar Therapeutics NKTR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-680	Closed	-$55K	–	497
2022 Q1	$55K	Sell	680 -553	-45%	-$44.7K	0.02%	364
2021 Q4	$249K	Buy	1,233 +206	+20%	+$41.6K	0.1%	177
2021 Q3	$276K	Buy	+1,027	New	+$276K	0.11%	164